凤凰城 - Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) 周二宣布，世界卫生组织 (WHO)已批准olastrocel作为其主要疗法CELZ-201活性细胞物质的国际非专有名称。这家目前市值仅为928万美元、股价为2.51美元的微型生物科技公司，近几个月来股价波动显著。

In this issue: 2026 forecast for the medtech industry, highlights from MEDICA 2025, Estonia's digital health DNA, and more ...

The Dr. Zachary Solomon Medical Tech Grant today announced a national call for applications from undergraduate students ...

A new national report has found that Australians are facing an average five-year wait for life-saving medical technologies.

Platform as a service allows the health-care industry to access, develop, and run applications on a single platform, reducing the use of resources needed to drive transformation. Provided bySiemens ...

More than a year into the generative artificial intelligence (gen AI) revolution, we are still seeing huge variability in what adoption actually looks like. Some industries have forged ahead, creating ...

Visitors are experiencing ''Gastrointestinal endoscopy'' at the 30th China International Medical Instruments and Equipment ...

For most people, including busy entrepreneurs, the concept of “taking care of your body” has usually meant visiting a doctor once a year and going over some routine lab results. However, advancements ...

The globally anticipated medical-technology and blockchain convergence project Vicpbin (VPB) has officially launched on the ...

Medical imaging technology is no longer just tied to radiology departments and cart-based systems. Handheld imaging devices can now be employed in any office or patient setting and can deliver fast ...

Technological advances are transforming medicine, but it may be making your physician less creative. Are technological advances making doctors lose the art of medicine? Of the many patients waiting to ...